Asenapine Transdermal Patch (Livzon Pharmaceutical/LTS Lohmann Therapie-Systeme)

阿塞那平透皮贴剂（（丽安香港）

Report date: 2026/05/27 14:26:49

Base Information

Drug NameAsenapine Transdermal Patch (Livzon Pharmaceutical/LTS Lohmann Therapie-Systeme)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D1 receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D1 receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyMacauHong Kong +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLian Hong Kong Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLian Hong Kong LtdLivzon Pharmaceutical Group IncLts Lohmann Therapie-Systeme Ag
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A